SCHEMBL9314968

SCHEMBL9314968

NCCC(C(=O)O)c1nc2ccccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.53
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.49
POLB P06746 1/20 0.49
CYP3A4 P08684 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
FPR1 P21462 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALOX12 P18054 1/20 0.46
CHRM1 P11229 1/20 0.46
MLKL Q8NB16 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433448 0.87 ALDH1A1 (0.56) IDO1KMT2AALDH1A1POLBCYP3A4
SCHEMBL5626297 0.84 KMT2A (0.57) IDO1KMT2AALDH1A1POLBCYP3A4
SCHEMBL28419559 0.82 ALDH1A1 (0.58) IDO1KMT2AALDH1A1FPR1SMN1; SMN2
SCHEMBL28416316 0.82 ALDH1A1 (0.58) IDO1KMT2AALDH1A1FPR1SMN1; SMN2
SCHEMBL28415424 0.82 ALDH1A1 (0.58) IDO1KMT2AALDH1A1FPR1SMN1; SMN2
SCHEMBL28421573 0.82 ALDH1A1 (0.58) IDO1KMT2AALDH1A1FPR1SMN1; SMN2
SCHEMBL28420241 0.82 ALDH1A1 (0.58) IDO1KMT2AALDH1A1FPR1SMN1; SMN2
SCHEMBL6063463 0.82 IDO1 (0.53) IDO1KMT2AALDH1A1POLBCYP3A4
Methylamine SCHEMBL10866955 0.82 KMT2A (0.52) IDO1KMT2AALDH1A1POLBCYP3A4
Ammonia Solution, Strong SCHEMBL10866532 0.81 IDO1 (0.51) IDO1KMT2AALDH1A1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed